# Nipro Corporation

> Nipro Corporation is a VC fund in Osaka backing Health Care, Therapeutics and Biotechnology. See 2 investments, round sizes, portfolio. Updated Sep 2026.

- Type: VC Fund
- Location: Osaka, Japan
- Total investments: 2
- Last investment: Oct 2020
- Lead investor: 100%
- Last updated: Sep 2026
- LinkedIn: https://www.linkedin.com/company/nipro-medical-corporation
- X (Twitter): https://www.twitter.com/nipromedicalus
- Website: https://www.nipro.co.jp/en/

Nipro Corporation is a Japanese medical equipment manufacturing company. Founded in 1954, the company is headquartered in Osaka and is listed on the Tokyo Stock Exchange and the Osaka Securities Exchange.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Ireland | 1 | 50% |
| United Kingdom | 1 | 50% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Venari Medical | Venari Medical’s mission focus is on the innovation of unparalleled safe, effective, patient-centered medical devices that improve quality of life for those with debilitating vascular disease.Venari Medical are developing BioVena™ - a more effective, less invasive, and faster treatment for all venous disease patients. It is uniquely positioned todisrupt current treatment practices which have seen only medium level innovation in the past decade. The team is based at Ireland's medtech cluster in Galway.Only 1.3 million of the 120 million people in the US & EU who suffer from venous disease currently receive endovenous treatment each year. 3 million venous ulcer patients are completely unserved, using ineffective compression bandaging. Venari Medical offers an unrivaled lower risk and unparalleled effective non-thermal treatment which will allow more patients who suffer from Venous Disease to access effective treatment.The indication for the use of superficial venous ablation is also set to widen to treat venous ulcers that currently incur annual costs of $33Bn to insurers in the US & EU. The Venari Medical technology can be used as a safe and effective treatment for the whole spectrum of Venous Disease from varicose veins to active venous ulcers. | $5.3M | Seed | Oct 28, 2020 | https://www.venarimedical.com |
| TC BioPharm | TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors. TC BioPharm’s mission is to develop and commercialize innovative cell-based products to treat disease, improving patient health and quality of life.TC BioPharm is a clinical development company with a cell-based product pipeline capable oftreating a variety of disorders, including cancer and severe viral infections. TCB is currently conducting Phase II/III clinical studies of its lead product, ImmuniCell, in renal cell cancinoma, non-small cell lung cancer and melanoma patients. | $7.9M | Series A | Jan 31, 2017 | http://www.tcbiopharm.com/ |

2 of 2 investments shown.

## Co-investors
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund, 1 deal together
- [Scottish Investment Bank](https://shizune.co/investors/profile/scottish-investment-bank) — VC Fund, 1 deal together
- [Western Development Commission](https://shizune.co/investors/profile/western-development-commission) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund
- [NDRC](https://shizune.co/investors/profile/ndrc) — VC Fund
- [Act Venture Capital](https://shizune.co/investors/profile/act-venture-capital) — VC Fund

## Featured in investor lists
- [Health Care Investors in Ireland](https://shizune.co/investors/health-care-investors-ireland)
- [Medical Device VC Funds in Ireland](https://shizune.co/investors/medical-device-vc-funds-ireland)
- [Medical Device Investors in Ireland](https://shizune.co/investors/medical-device-investors-ireland)

## FAQ

### What does Nipro Corporation invest in?

Nipro Corporation invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Nipro Corporation last invest?

The most recent investment recorded for Nipro Corporation closed in Oct 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co